(Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, ...

Investing.com -- The American College of Cardiology released new recommendations on Friday stating that millions more ...